LGND
LigandCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-23
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
LGND vs peer average
57/100
LGND vs. peer average (C vs. C)
Grade spread
A 1 · C 2 · D 6
Graded peers loaded
Coverage
9 graded
90% of tracked
Peer overview
RPRX is the first available peer comparator.
Royalty Pharma remains the clearest public model peer for diversified biopharma royalty cash-flow valuation, even though it operates at much larger scale.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
LGND
Ligand
RPRX
Royalty
Grade
C
D
Momentum
89
51
Value
59
63
Sentiment
20
27
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Defensive
Grade position vs RPRX
LGND / RPRX
Grade Position
In line
LGND vs. peer average (C vs. C)
57/100
Momentum
89
LGNDValue
59
RPRXSentiment
20
RPRXRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs LGND
RPRX is the first peer returned for this comparison set.